MARSHALL WACE, LLP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$33,538,201
-21.5%
940,763
+1.5%
0.07%
-18.1%
Q2 2023$42,745,765
+17.7%
926,637
+2.3%
0.08%
+7.8%
Q1 2023$36,311,553
+133.7%
905,525
+170.0%
0.08%
+120.0%
Q4 2022$15,540,240
+365.0%
335,425
+315.6%
0.04%
+400.0%
Q3 2022$3,342,000
-84.1%
80,714
-77.0%
0.01%
-83.7%
Q2 2022$20,979,000
-25.1%
351,650
-8.8%
0.04%
-18.9%
Q1 2022$27,993,000
+42.1%
385,453
+64.6%
0.05%
+47.2%
Q4 2021$19,697,000
+629.5%
234,230
+682.3%
0.04%
+227.3%
Q3 2021$2,700,000
-20.3%
29,942
-15.7%
0.01%
-26.7%
Q2 2021$3,388,000
-5.9%
35,529
+36.6%
0.02%
-25.0%
Q4 2020$3,601,000
+8.2%
26,014
-12.3%
0.02%
-35.5%
Q4 2015$3,327,000
-53.3%
29,656
-59.9%
0.03%
-64.8%
Q3 2015$7,126,000
+16.1%
73,993
+23.4%
0.09%
+10.0%
Q2 2015$6,138,000
-19.4%
59,949
-51.1%
0.08%
-19.2%
Q1 2015$7,613,000122,6130.10%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2021
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders